With Covid-19 no longer classed as a global emergency, even though it continues to kill, many experts are focusing their attention on the next danger: Disease X.
This is the as-yet-unidentified source of the next global pandemic, an event sometimes said to be a question of “when” rather than “if”.
Disease X is not an actual condition, but instead represents the reality that, in the World Health Organisation’s words, “a serious international epidemic could be caused by a pathogen currently unknown to cause human disease”.
The WHO began to include Disease X on its list of priority diseases – those that pose the greatest risk and for which countermeasures are inadequate – in 2018, the year before the novel coronavirus emerged in the Chinese city of Wuhan.
The coronavirus has since infected hundreds of millions and caused about seven million deaths, according to official figures, although the true number is thought to be much higher.
“Clearly Covid has changed most people’s perspective in that it did happen and happened in a big way. I suppose people are concerned something could come along and be similarly or even more devastating,” said Dr Andrew Freedman, an infectious diseases specialist at Cardiff University in the UK.
Many types of pathogens could cause Disease X, although most experts, including Dr Freedman, put another coronavirus or an influenza virus at the top of their list of dangers.
In military parlance, Disease X is a “known unknown” in that it may come from an existing pathogen that, like SARS-CoV-2, which causes Covid-19, jumped the species barrier and began infecting humans.
Some pathogens that have already infected people cause scientists concern, among them the virus that causes Middle East Respiratory Syndrome, or Mers.
The Mers coronavirus infects camels, and many of the people who have fallen ill have been those with close contact with the animals. Person-to-person transmission is rare, but the virus could mutate in a way that would make this easier.
“If there’s human-to-human transmission it’s a huge issue,” said Dr Bharat Pankhania, a senior consultant in communicable disease control and senior clinical lecturer at the University of Exeter in the UK.
Ebola and Marburg, which are both filoviruses, have very high fatality rates, but they are more easily contained because they are not respiratory viruses, said Dr Freedman.
“There have been big outbreaks, but the potential to cause a pandemic that spreads across the world is much lower,” he said.
The increase in antibiotic resistance among bacteria has been cited as a threat as big as another pandemic, with a 2019 UN report warning that by 2050 there could be 10 million deaths annually because some microorganisms cannot be tackled.
Yet this week news emerged that artificial intelligence has identified a new antibiotic, abaucin, that could be used to kill Acinetobacter baumannii, a bacterium that has been branded a superbug.
Technological breakthroughs were also much in evidence during the Covid-19 pandemic, notably with the successful emergence of mRNA vaccines, which could be designed and deployed at speed if or when another deadly pathogen – most likely viral – emerges.
With the Covid experience, we know we can develop vaccines, so we’re in a much better place compared to 2019
Dr Bharat Pankhania,
expert in communicable disease control
“With the Covid experience, we know we can develop vaccines, so we’re in a much better place compared to 2019,” Dr Pankhania said.
However, the risks of something “unexpected, unusual, unknown, unheard” emerging is higher than it used to be, Dr Pankhania warned, because many people live in proximity to wild animals, which are a probable source of pathogens that could spread to humans.
“There’s every possibility of something jumping from an animal into a human, then humans to humans,” Dr Pankhania said.
The continued trade in live animals in markets in China in particular remains a concern, Dr Freedman said, as do farming practices.
Compassion in World Farming, a pressure group that campaigns against intensive or factory farming, states that “the stressful, crowded conditions on factory farms help drive the emergence and spread of dangerous, infectious diseases”.
Another potential source of a pandemic is a leak from a laboratory. The Wuhan Institute of Virology, in the city where the novel coronavirus emerged, fell under the spotlight because it carried out research into coronaviruses.
There are conflicting hypotheses, so it is unlikely to ever be known whether Covid-19 was the result of a lab leak or if the coronavirus spread to people from an animal at a market in the city.
Since the Covid-19 pandemic, more countries are building biosecure laboratories to carry out work on hazardous pathogens.
A recent report by universities in the UK and US spoke of a “global boom in construction”, increasing the number of centres from which such a leak could happen.
Stringent security procedures reduce the risks, but analysts have said that a leak could be deliberate, such as if a staff member tried to launch a bioterrorism attack.
So, five years on from when the WHO first highlighted the dangers posed by Disease X, the threats remain many and varied, although the world is better equipped than ever to tackle whatever emerges.
MATCH INFO
Karnatake Tuskers 114-1 (10 ovs)
Charles 57, Amla 47
Bangla Tigers 117-5 (8.5 ovs)
Fletcher 40, Moores 28 no, Lamichhane 2-9
Bangla Tiger win by five wickets
More from Neighbourhood Watch:
Walls
Louis Tomlinson
3 out of 5 stars
(Syco Music/Arista Records)
PROFILE OF SWVL
Started: April 2017
Founders: Mostafa Kandil, Ahmed Sabbah and Mahmoud Nouh
Based: Cairo, Egypt
Sector: transport
Size: 450 employees
Investment: approximately $80 million
Investors include: Dubai’s Beco Capital, US’s Endeavor Catalyst, China’s MSA, Egypt’s Sawari Ventures, Sweden’s Vostok New Ventures, Property Finder CEO Michael Lahyani
The years Ramadan fell in May
Pari
Produced by: Clean Slate Films (Anushka Sharma, Karnesh Sharma) & KriArj Entertainment
Director: Prosit Roy
Starring: Anushka Sharma, Parambrata Chattopadhyay, Ritabhari Chakraborty, Rajat Kapoor, Mansi Multani
Three stars
Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.
Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.
“Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.
Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.
“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.
Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.
From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.
Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.
BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.
Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.
Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.
“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.
Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.
“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.
“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”
The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”
Libya's Gold
UN Panel of Experts found regime secretly sold a fifth of the country's gold reserves.
The panel’s 2017 report followed a trail to West Africa where large sums of cash and gold were hidden by Abdullah Al Senussi, Qaddafi’s former intelligence chief, in 2011.
Cases filled with cash that was said to amount to $560m in 100 dollar notes, that was kept by a group of Libyans in Ouagadougou, Burkina Faso.
A second stash was said to have been held in Accra, Ghana, inside boxes at the local offices of an international human rights organisation based in France.
Company%20Profile
%3Cp%3E%3Cstrong%3EName%3A%3C%2Fstrong%3E%20Raha%3Cbr%3E%3Cstrong%3EStarted%3A%3C%2Fstrong%3E%202022%3Cbr%3E%3Cstrong%3EBased%3A%3C%2Fstrong%3E%20Kuwait%2FSaudi%3Cbr%3E%3Cstrong%3EIndustry%3A%3C%2Fstrong%3E%20Tech%20Logistics%3Cbr%3E%3Cstrong%3EFunding%3A%3C%2Fstrong%3E%20%2414%20million%3Cbr%3E%3Cstrong%3EInvestors%3A%3C%2Fstrong%3E%20Soor%20Capital%2C%20eWTP%20Arabia%20Capital%2C%20Aujan%20Enterprises%2C%20Nox%20Management%2C%20Cedar%20Mundi%20Ventures%3Cbr%3E%3Cstrong%3ENumber%20of%20employees%3A%3C%2Fstrong%3E%20166%3C%2Fp%3E%0A
Killing of Qassem Suleimani
Our family matters legal consultant
Name: Hassan Mohsen Elhais
Position: legal consultant with Al Rowaad Advocates and Legal Consultants.
Our family matters legal consultant
Name: Hassan Mohsen Elhais
Position: legal consultant with Al Rowaad Advocates and Legal Consultants.
Uefa Nations League
League A:
Germany, Portugal, Belgium, Spain, France, England, Switzerland, Italy, Poland, Iceland, Croatia, Netherlands
League B:
Austria, Wales, Russia, Slovakia, Sweden, Ukraine, Republic of Ireland, Bosnia-Herzegovina, Northern Ireland, Denmark, Czech Republic, Turkey
League C:
Hungary, Romania, Scotland, Slovenia, Greece, Serbia, Albania, Norway, Montenegro, Israel, Bulgaria, Finland, Cyprus, Estonia, Lithuania
League D:
Azerbaijan, Macedonia, Belarus, Georgia, Armenia, Latvia, Faroe Islands, Luxembourg, Kazakhstan, Moldova, Liechtenstein, Malta, Andorra, Kosovo, San Marino, Gibraltar
Results
Female 49kg: Mayssa Bastos (BRA) bt Thamires Aquino (BRA); points 0-0 (advantage points points 1-0).
Female 55kg: Bianca Basilio (BRA) bt Amal Amjahid (BEL); points 4-2.
Female 62kg: Beatriz Mesquita (BRA) v Ffion Davies (GBR); 10-2.
Female 70kg: Thamara Silva (BRA) bt Alessandra Moss (AUS); submission.
Female 90kg: Gabreili Passanha (BRA) bt Claire-France Thevenon (FRA); submission.
Male 56kg: Hiago George (BRA) bt Carlos Alberto da Silva (BRA); 2-2 (2-0)
Male 62kg: Gabriel de Sousa (BRA) bt Joao Miyao (BRA); 2-2 (2-1)
Male 69kg: Paulo Miyao (BRA) bt Isaac Doederlein (USA); 2-2 (2-2) Ref decision.
Male 77kg: Tommy Langarkar (NOR) by Oliver Lovell (GBR); submission.
Male 85kg: Rudson Mateus Teles (BRA) bt Faisal Al Ketbi (UAE); 2-2 (1-1) Ref decision.
Male 94kg: Kaynan Duarte (BRA) bt Adam Wardzinski (POL); submission.
Male 110kg: Joao Rocha (BRA) bt Yahia Mansoor Al Hammadi (UAE); submission.